FDA Inspection 921199 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 1000161089

The FDA completed an inspection of Mary Bird Perkins Cancer Center on Apr 2, 2015 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 2, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.